4D Molecular Therapeutics Inc
NASDAQ:FDMT 3:59:44 PM EDT
| Market Cap (Intraday) | 969.03M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $37.75 |
| 50-Day MA | $43.21 |
| 200-Day MA | N/A |
4D Molecular Therapeutics, Inc. Stock, NASDAQ:FDMT
5858 Horton Street, Suite 455, Emeryville, California 94608
United States of America
Phone: +1.510.505.2680
Number of Employees:
Description
4D Molecular Therapeutics, Inc. designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. It offers lysosomal storage disease, lung disease, muscular dystrophy, and ophthalmological disease services. The company was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer in 2013 and is headquartered in Emeryville, CA.